Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
349 participants
INTERVENTIONAL
2008-04-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Montefiore Metoclopramide Study
NCT00475306
Prochlorperazine vs Metoclopramide
NCT00364806
Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial
NCT02314351
Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine
NCT04252521
Metoclopramide in Upper Gastrointestinal Bleed
NCT05746377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Metoclopramide 10 mg+ diphenhydramine 25 mg. This medication was administered as an intravenous drip over 20 minutes
metoclopramide
metoclopramide 10 mg
Diphenhydramine 25mg
Diphenhydramine 25mg, administered as an intravenous drip over 20 minutes
2
metoclopramide 20 mg + diphenhydramine 25 mg. Administered as an intravenous drip over 20 minutes.
metoclopramide
metoclopramide 20 mg
Diphenhydramine 25mg
Diphenhydramine 25mg, administered as an intravenous drip over 20 minutes
3
metoclopramide 40 mg + diphenhdyramine 25mg. Administered as an intravenous drip over 20 minutes.
metoclopramide
metoclopramide 40 mg
Diphenhydramine 25mg
Diphenhydramine 25mg, administered as an intravenous drip over 20 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
metoclopramide
metoclopramide 20 mg
metoclopramide
metoclopramide 40 mg
metoclopramide
metoclopramide 10 mg
Diphenhydramine 25mg
Diphenhydramine 25mg, administered as an intravenous drip over 20 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* lumbar puncture
* allergy or intolerance to study medication
18 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montefiore Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin W. Friedman, MD
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin W. Friedman, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Montefiore Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montefiore Medical Center
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-11-405
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.